Literature DB >> 11704931

Spinal neurofibromatosis without café-au-lait macules in two families with null mutations of the NF1 gene.

D Kaufmann1, R Müller, B Bartelt, M Wolf, K Kunzi-Rapp, C O Hanemann, R Fahsold, C Hein, W Vogel, G Assum.   

Abstract

Spinal neurofibromatosis (SNF) is considered to be an alternative form of neurofibromatosis, showing multiple spinal tumors and café-au-lait macules. Involvement of the neurofibromatosis type 1 (NF1) locus has been demonstrated, by linkage analysis, for three families with SNF. In one of them, a cosegregating frameshift mutation in exon 46 of the NF1 gene was identified. In the present study, we report four individuals from two families who carry NF1 null mutations that would be expected to cause NF1. Three patients have multiple spinal tumors and no café-au-lait macules, and the fourth has no clinical signs of NF1. In the first family, a missense mutation (Leu2067Pro) in NF1 exon 33 was found, and, in the second, a splice-site mutation (IVS31-5A-->G) enlarging exon 32 by 4 bp at the 5' end was found. The latter mutation has also been observed in an unrelated patient with classical NF1. Both NF1 mutations cause a reduction in neurofibromin of approximately 50%, with no truncated protein present in the cells. This demonstrates that typical NF1 null mutations can result in a phenotype that is distinct from classical NF1, showing only a small spectrum of the NF1 symptoms, such as multiple spinal tumors, but not completely fitting the current clinical criteria for SNF. We speculate that this phenotype is caused by an unknown modifying gene that compensates for some, but not all, of the effects caused by neurofibromin deficiency.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11704931      PMCID: PMC1235551          DOI: 10.1086/324648

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  16 in total

1.  Mutational analysis and expression studies of the neurofibromatosis type 2 (NF2) gene in a patient with a ring chromosome 22 and NF2.

Authors:  H Kehrer-Sawatzki; M Udart; W Krone; R Baden; R Fahsold; G Thomas; B Schmucker; G Assum
Journal:  Hum Genet       Date:  1997-07       Impact factor: 4.132

2.  Post-transcriptional regulation of neurofibromin level in cultured human melanocytes in response to growth factors.

Authors:  J Griesser; D Kaufmann; B Maier; R Mailhammer; P Kuehl; W Krone
Journal:  J Invest Dermatol       Date:  1997-03       Impact factor: 8.551

3.  A clinical study of type 1 neurofibromatosis in north west England.

Authors:  J M McGaughran; D I Harris; D Donnai; D Teare; R MacLeod; R Westerbeek; H Kingston; M Super; R Harris; D G Evans
Journal:  J Med Genet       Date:  1999-03       Impact factor: 6.318

4.  EVI2B, a gene lying in an intron of the neurofibromatosis type 1 (NF1) gene, is as the NF1 gene involved in differentiation of melanocytes and keratinocytes and is overexpressed in cells derived from NF1 neurofibromas.

Authors:  D Kaufmann; S Gruener; F Braun; M Stark; J Griesser; S Hoffmeyer; B Bartelt
Journal:  DNA Cell Biol       Date:  1999-05       Impact factor: 3.311

5.  Toward a survey of somatic mutation of the NF1 gene in benign neurofibromas of patients with neurofibromatosis type 1.

Authors:  I Eisenbarth; K Beyer; W Krone; G Assum
Journal:  Am J Hum Genet       Date:  2000-02       Impact factor: 11.025

6.  Spinal tumours in neurofibromatosis type 1: an MRI study of frequency, multiplicity and variety.

Authors:  S D Thakkar; U Feigen; V F Mautner
Journal:  Neuroradiology       Date:  1999-09       Impact factor: 2.804

7.  A clinical variant of neurofibromatosis type 1: familial spinal neurofibromatosis with a frameshift mutation in the NF1 gene.

Authors:  E Ars; H Kruyer; A Gaona; P Casquero; J Rosell; V Volpini; E Serra; C Lázaro; X Estivill
Journal:  Am J Hum Genet       Date:  1998-04       Impact factor: 11.025

8.  Minor lesion mutational spectrum of the entire NF1 gene does not explain its high mutability but points to a functional domain upstream of the GAP-related domain.

Authors:  R Fahsold; S Hoffmeyer; C Mischung; C Gille; C Ehlers; N Kücükceylan; M Abdel-Nour; A Gewies; H Peters; D Kaufmann; A Buske; S Tinschert; P Nürnberg
Journal:  Am J Hum Genet       Date:  2000-03       Impact factor: 11.025

9.  On unequal allelic expression of the neurofibromin gene in neurofibromatosis type 1.

Authors:  S Hoffmeyer; G Assum; J Griesser; D Kaufmann; P Nürnberg; W Krone
Journal:  Hum Mol Genet       Date:  1995-08       Impact factor: 6.150

10.  Selective disactivation of neurofibromin GAP activity in neurofibromatosis type 1.

Authors:  A Klose; M R Ahmadian; M Schuelke; K Scheffzek; S Hoffmeyer; A Gewies; F Schmitz; D Kaufmann; H Peters; A Wittinghofer; P Nürnberg
Journal:  Hum Mol Genet       Date:  1998-08       Impact factor: 6.150

View more
  6 in total

1.  Familial spinal neurofibromatosis due to a multiexonic NF1 gene deletion.

Authors:  Antonio Pizzuti; Irene Bottillo; Francesca Inzana; Valentina Lanari; Francesca Buttarelli; Isabella Torrente; Anna Teresa Giallonardo; Alessandro De Luca; Bruno Dallapiccola
Journal:  Neurogenetics       Date:  2011-03-02       Impact factor: 2.660

2.  Next-generation sequencing identifies rare variants associated with Noonan syndrome.

Authors:  Peng-Chieh Chen; Jiani Yin; Hui-Wen Yu; Tao Yuan; Minerva Fernandez; Christina K Yung; Quang M Trinh; Vanya D Peltekova; Jeffrey G Reid; Erica Tworog-Dube; Margaret B Morgan; Donna M Muzny; Lincoln Stein; John D McPherson; Amy E Roberts; Richard A Gibbs; Benjamin G Neel; Raju Kucherlapati
Journal:  Proc Natl Acad Sci U S A       Date:  2014-07-21       Impact factor: 11.205

3.  Segmental spinal neurofibromatosis 1: a novel phenotype.

Authors:  Nida Fatima; Anna La Dine; Zachary R Barnard; Gregory P Lekovic
Journal:  Neurol Sci       Date:  2022-05-20       Impact factor: 3.830

4.  The spectrum of somatic and germline NF1 mutations in NF1 patients with spinal neurofibromas.

Authors:  Meena Upadhyaya; Gill Spurlock; Lan Kluwe; Nadia Chuzhanova; Emma Bennett; Nick Thomas; Abhijit Guha; Victor Mautner
Journal:  Neurogenetics       Date:  2009-02-17       Impact factor: 2.660

5.  Altered calcium-mediated cell signaling in keratinocytes cultured from patients with neurofibromatosis type 1.

Authors:  Timo Korkiamäki; Heli Ylä-Outinen; Jussi Koivunen; Seija-Liisa Karvonen; Juha Peltonen
Journal:  Am J Pathol       Date:  2002-06       Impact factor: 4.307

Review 6.  Do non-pathogenic variants of DNA mismatch repair genes modify neurofibroma load in neurofibromatosis type 1?

Authors:  Anja Harder
Journal:  Childs Nerv Syst       Date:  2022-01-08       Impact factor: 1.475

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.